Multicenter Randomized Phase III Study Evaluating the Role of High-Dose Chemotherapy and Peripheral Blood Progenitor Cell Support in Patients with Limited-Stage Small-Cell Lung Cancer

Publisher： Karger

E-ISSN： 2296-5262|21|2|12-14

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.21, Iss.2, 1998-06, pp. : 12-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

A Multicenter Phase II Study of the Combination of Irinotecan and Gemcitabine in Previously Treated Patients with Small-Cell Lung Cancer

By  

Oncology, Vol. 66, Iss. 3, 2004-06 ,pp. : 192-196

Karger

Access to resources Recommend Favorite

The Role of Integrated 18F-FDG PET-CT as a Staging Tool for Limited-Stage Small Cell Lung Cancer: A Retrospective Study

By  

Oncology Research and Treatment, Vol. 35, Iss. 7-8, 2012-07 ,pp. : 432-438

Karger

Access to resources Recommend Favorite

Progress in the management of limited‐stage small cell lung cancer

By  

CANCER, Vol. 120, Iss. 6, 2014-03 ,pp. : 790-798

John Wiley & Sons Inc

Access to resources Recommend Favorite

Limited-Stage Small Cell Lung Cancer: How to Optimize Therapy?

By  

Oncology Research and Treatment, Vol. 35, Iss. 6, 2012-05 ,pp. : 332-333

Karger

Access to resources Recommend Favorite

Prognostic Analysis of Limited-Stage Small Cell Lung Cancer after Chemoradiotherapy

By  

Oncology Research and Treatment, Vol. 35, Iss. 6, 2012-05 ,pp. : 362-367

Karger

Access to resources Recommend Favorite